IBX-001-026
N/A
Report date: 2022/11/12 16:46:33
NME
Base Information
Drug NameIBX-001-026
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAquavit Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesAquavit Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A